| Sky Metals Limited (SKY) ORDINARY FULLY PAID |
Materials |
$173 |
Quarterly Cashflow Report - December 2025
|
23 Jan 2026 8:54AM |
$0.165 |
$0.175 |
risen by
6.06%
|
|
SKY - Price-sensitive ASX Announcement
Full Release
Key Points
- Sky Metals Limited reported a net cash outflow from operating activities of $449,000 for the current quarter.
- Investing activities resulted in a net cash outflow of $1,464,000, primarily due to significant exploration and evaluation expenditures.
- Financing activities provided a net cash inflow of $592,000, largely from the issuance of equity securities.
- The company ended the period with cash and cash equivalents of $4,701,000.
- Payments to related parties included $54,000 for directors and consulting fees.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Flight Centre Travel Group Limited (FLT) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,741 |
Update - Notification of buy-back - FLT
|
23 Jan 2026 8:53AM |
$15.500 |
$12.900 |
fallen by
16.77%
|
|
| Franklin Australian Absolute Return Bond Fund (Managed Fund) (FRAR) |
Financials |
$716 |
Indicative Distribution Calendar 31 January 2026
|
23 Jan 2026 8:52AM |
$1.045 |
$1.045 |
fallen by
0%
|
|
| Delta Lithium Limited (DLI) ORDINARY FULLY PAID |
Materials |
$176 |
Lithium Exploration Update
|
23 Jan 2026 8:52AM |
$0.290 |
$0.245 |
fallen by
15.52%
|
|
DLI - Price-sensitive ASX Announcement
Full Release
Key Points
- Mt Ida project contains advanced lithium, tantalum, and rubidium resources.
- Total JORC MRE at Mt Ida is 14.8Mt at 1.2% Li2O.
- Successful production of 99.8% lithium carbonate from Mt Ida mica concentrate.
- Yinnetharra Lithium Project spans over 2,300 km².
- Yinnetharra MRE is 21.9Mt at 1.0% Li2O.
- Current exploration programs are ongoing with significant lithium intercepts.
- Delta's cash balance is $54 million as of 31 December 2025.
- Additional investments valued at $145 million as of 20 January 2026.
- Continued focus on exploration and development in Western Australia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nyrada Inc (NYR) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$163 |
Quarterly Activities Report and Appendix 4C
|
23 Jan 2026 8:52AM |
$0.935 |
$0.665 |
fallen by
28.88%
|
|
NYR - Price-sensitive ASX Announcement
Full Release
Key Points
- HREC approval received for Phase IIa clinical trial of Xolatryp®.
- Patient recruitment for clinical trial to start in March 2026.
- AU$7.12 million cash balance as of 31 December 2025.
- Expected R&D tax rebate of AU$2.16 million for FY2025.
- Phase IIa trial to assess safety and preliminary efficacy in heart attack patients.
- Initiation of preclinical studies for oncology indications.
- Trademark granted for Xolatryp in medicinal and health services.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Arovella Therapeutics Limited (ALA) ORDINARY FULLY PAID |
Health Care |
$99 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
23 Jan 2026 8:51AM |
$0.090 |
$0.082 |
fallen by
8.89%
|
|
ALA - Price-sensitive ASX Announcement
Full Release
Key Points
- Cash and cash equivalents at 31 December of $19.4 million.
- IND application for ALA-101 submitted to U.S. FDA.
- Preparation for first-in-human phase 1 trial for ALA-101 initiated.
- Demonstrated activity of CLDN18.2-targeting CAR for ALA-105.
- In-licensing additional CAR targets and technology from Baylor College of Medicine.
- Appointment of Dr. Andrew Nash as a Non-Executive Director.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PYC Therapeutics Limited (PYC) ORDINARY FULLY PAID |
Health Care |
$1,417 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
23 Jan 2026 8:50AM |
$1.665 |
$1.505 |
fallen by
9.61%
|
|
PYC - Price-sensitive ASX Announcement
Full Release
Key Points
- PYC Therapeutics Limited is a precision medicine company focusing on RNA therapeutics.
- The company is developing drug candidates for diseases like Polycystic Kidney Disease, Autosomal Dominant Optic Atrophy, Retinitis Pigmentosa type 11, and Phelan-McDermid Syndrome.
- The company's vision is to create life-changing impact for patients with genetic diseases.
- PYC reported a net cash outflow from operating activities of AUD 13,760,000 for the quarter.
- As of 31 December 2025, PYC had cash and cash equivalents of AUD 120,692,000.
- The company has four drug candidates with three already in human trials.
- PYC expects to complete significant clinical trials and regulatory steps by 2026.
- Payments to related parties in the quarter amounted to AUD 128,000.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bounty Oil & Gas NL (BUY) ORDINARY FULLY PAID |
Energy |
$3 |
Board and Management Renewal
|
23 Jan 2026 8:50AM |
$0.003 |
$0.002 |
fallen by
33.33%
|
|
BUY - Price-sensitive ASX Announcement
Full Release
Key Points
- Kane Marshall appointed as Independent Non-Executive Director and Chairman.
- Robin Armstrong appointed as Independent Non-Executive Director.
- Retirement of Non-Executive Directors Graham Reveleigh and Charles Ross.
- Retirement of CEO Philip Kelso.
- Focus on strengthening leadership for asset development and new ventures.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Korvest Ltd (KOV) ORDINARY FULLY PAID |
Industrials |
$186 |
Investor Presentation
|
23 Jan 2026 8:48AM |
$14.300 |
$15.740 |
risen by
10.07%
|
|
KOV - Price-sensitive ASX Announcement
Full Release
Key Points
- Korvest Ltd (ASX:KOV) is headquartered in South Australia and provides cable and pipe supports along with galvanising services.
- The company experienced revenue and earnings growth compared to the previous corresponding period (PCP).
- Korvest has a solid pipeline of major infrastructure projects secured for the second half of FY26 and beyond.
- Significant project work expansion is noted, with both major and small projects increasing compared to PCP.
- The company successfully transitioned its ERP system and completed major upgrades to its galvanising operations, including a new kettle and burner management system.
- Korvest's Kilburn expansion is underway, focusing on factory automation and increased capacity.
- Dividend distribution includes a consistent interim dividend of 25¢ per share and a final dividend of 40¢, with a special dividend of 10¢ for FY26.
- The company has a national sales and warehouse network and a strong overseas supply chain, providing flexibility in make vs buy decisions.
- Korvest is focusing on growth in day-to-day and small project markets, as well as infrastructure, data centre, and large project pipelines.
- FY26 capital expenditure focuses on new equipment for enhanced capability and capacity, including development at Kilburn and a new Brisbane site.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| American Tungsten and Antimony Ltd (AT4) ORDINARY FULLY PAID |
Materials |
$189 |
AT4 SIGNS WITH DEUTSCHE BANK FOR NASDAQ LISTING
|
23 Jan 2026 8:48AM |
$0.165 |
$0.145 |
fallen by
12.12%
|
|
AT4 - Price-sensitive ASX Announcement
Full Release
Key Points
- American Tungsten & Antimony Ltd (AT4) is advancing towards a proposed listing on Nasdaq.
- Deutsche Bank has been appointed as the depositary for an American Depositary Receipt (ADR) program.
- The ADR program will allow US investors to acquire ADRs, accessible initially in the over-the-counter market and later on Nasdaq.
- The company aims to submit a confidential registration statement on Form 20-F to the US SEC in March 2026, with an anticipated listing on Nasdaq in Q2 2026.
- Graeme Morissey has been appointed as the new Chief Financial Officer.
- The Nasdaq listing is expected to provide access to the world's largest equity capital markets, aligning with growing interest in critical minerals in the US.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Korvest Ltd (KOV) ORDINARY FULLY PAID |
Industrials |
$186 |
Press Release 1H FY26 Results
|
23 Jan 2026 8:47AM |
$14.300 |
$15.740 |
risen by
10.07%
|
|
| Westgold Resources Limited (WGX) ORDINARY FULLY PAID |
Materials |
$7,322 |
Ceasing to be a substantial holder
|
23 Jan 2026 8:46AM |
$7.270 |
$7.750 |
risen by
6.60%
|
|
| Clover Corporation Limited (CLV) ORDINARY FULLY PAID |
Materials |
$130 |
Notification of buy-back - CLV
|
23 Jan 2026 8:44AM |
$0.770 |
$0.780 |
risen by
1.30%
|
|
| Clover Corporation Limited (CLV) ORDINARY FULLY PAID |
Materials |
$130 |
On-Market Acquisition of shares by Employee Share Plan trust
|
23 Jan 2026 8:44AM |
$0.770 |
$0.780 |
risen by
1.30%
|
|
CLV - Price-sensitive ASX Announcement
Full Release
Key Points
- On-market acquisition of up to 3,264,167 shares by Employee Share Plan Trust.
- Acquisition to align employee performance with shareholder interests.
- Acquisition will avoid dilution of existing shareholders.
- Approval was obtained at AGM on 18 November 2025.
- Shares to be acquired at a price not more than 5% above the 10-day VWAP.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Venus Metals Corporation Limited (VMC) ORDINARY FULLY PAID |
Materials |
$48 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
23 Jan 2026 8:44AM |
$0.215 |
$0.245 |
risen by
13.95%
|
|
VMC - Price-sensitive ASX Announcement
Full Release
Key Points
- Venus Metals reported a negative net cash flow from operating activities of $268,000.
- The company held $1,383,000 in cash and cash equivalents at the quarter's end.
- A farm-in agreement for the Bridgetown-Greenbushes Project was extended to November 2028.
- Venus Metals is conducting pre-feasibility studies for the Bellchambers Project.
- Financial holdings include $26,282,000 in cash and investments.
- QGold Pty Ltd made an on-market takeover bid at $0.21 per share.
- The company is involved in exploration activities for gold, copper, and other metals in Western Australia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dalaroo Metals Ltd (DAL) ORDINARY FULLY PAID |
Materials |
$23 |
Dalaroo Fast-Tracks 2026 Exploration at Blue Lagoon
|
23 Jan 2026 8:43AM |
$0.074 |
$0.069 |
fallen by
6.76%
|
|
DAL - Price-sensitive ASX Announcement
Full Release
Key Points
- Dalaroo is fast-tracking 2026 exploration at Blue Lagoon after successful 2025 results.
- The 2026 program includes targeted geophysics, geochemical analysis, and auger drilling.
- Confirmed presence of rare earth elements, zirconium, and niobium across a 2.7 km strike.
- Objective is to de-risk Blue Lagoon, improve metallurgical understanding, and support critical mineral supply chains.
- Engagement and compliance with Greenland's local stakeholders and regulations are prioritized.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| NIB Holdings Limited (NHF) ORDINARY FULLY PAID |
Financials |
$3,128 |
Notice of Briefing - 2026 Half Year Results Presentation
|
23 Jan 2026 8:43AM |
$6.650 |
$6.410 |
fallen by
3.61%
|
|
| Korvest Ltd (KOV) ORDINARY FULLY PAID |
Industrials |
$186 |
Dividend/Distribution - KOV
|
23 Jan 2026 8:42AM |
$14.300 |
$15.740 |
risen by
10.07%
|
|
| Korvest Ltd (KOV) ORDINARY FULLY PAID |
Industrials |
$186 |
Half Yearly Report and Accounts
|
23 Jan 2026 8:41AM |
$14.300 |
$15.740 |
risen by
10.07%
|
|
KOV - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 17.9% to AUD 60.3 million.
- Net profit after tax increased by 33.2% to AUD 5.444 million.
- Dividends of 50.0¢ per share were paid.
- The EzyStrut business saw a 19.3% revenue increase.
- Total assets are AUD 91.44 million; net assets are AUD 60.569 million.
- The financial position was influenced by capital expenditures and dividends.
- Strong cash flow from operating activities, but a cash decrease due to other activities.
- Managed operational challenges affected costs and profit margins.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Golden Globe Resources Ltd (GGR) ORDINARY FULLY PAID |
Materials |
$33 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
23 Jan 2026 8:41AM |
$0.210 |
$0.295 |
risen by
40.48%
|
|
GGR - Price-sensitive ASX Announcement
Full Release
Key Points
- Successful completion of IPO and ASX listing.
- Raised $8.5 million to fund exploration projects.
- Commenced 4,000-metre drilling program at Dooloo Creek.
- Developed a new geological model for understanding mineralization.
- Strong financial position with $6.44 million in cash reserves.
- Planned exploration activities for Neila Creek and Alma projects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aristocrat Leisure Limited (ALL) ORDINARY FULLY PAID |
Consumer Discretionary |
$29,460 |
Update - Notification of buy-back - ALL
|
23 Jan 2026 8:37AM |
$57.730 |
$48.080 |
fallen by
16.72%
|
|
| Metro Mining Limited (MMI) ORDINARY FULLY PAID |
Materials |
$434 |
Changes to Executive Leadership Team
|
23 Jan 2026 8:36AM |
$0.070 |
$0.071 |
risen by
1.43%
|
|
| Coventry Group Limited (CYG) ORDINARY FULLY PAID |
Industrials |
$67 |
CYG 1H FY26 Trading Update
|
23 Jan 2026 8:35AM |
$0.550 |
$0.480 |
fallen by
12.73%
|
|
CYG - Price-sensitive ASX Announcement
Full Release
Key Points
- Coventry Group Ltd reported unaudited sales of $188.5 million and EBITDA of $3.2 million for 1H FY26.
- The company's performance improved compared to 2H FY25, attributed to early benefits from operating improvement initiatives.
- Coventry Group initiated a strategic review of its business portfolio, appointing Allier Capital and Talbot Sayer as advisors.
- The company managed net debt and working capital as planned, maintaining sufficient funding liquidity.
- A strategic review aims to unlock shareholder value, potentially leading to portfolio simplification or separation.
- The Board withdrew the company's previously issued FY26 earnings guidance due to potential outcomes from the strategic review.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Regal Asian Investments Limited (RG8) ORDINARY FULLY PAID |
Financials |
$440 |
Update - Notification of buy-back - RG8
|
23 Jan 2026 8:31AM |
$2.970 |
$3.020 |
risen by
1.68%
|
|
| Regal Partners Global Investments Limited (RG1) ORDINARY FULLY PAID |
Financials |
$558 |
Update - Notification of buy-back - RG1
|
23 Jan 2026 8:30AM |
$2.500 |
$2.310 |
fallen by
7.60%
|
|
Call 1300 880 160
Start a chat
Schedule a call
